ResMed

Yahoo Finance • 4 days ago

Markets Rebound, But Short Sellers Are Circling--Is This Rally Built to Last?

Short sellers turned up the heat on healthcare stocks in February, with Moderna (NASDAQ:MRNA) taking the top spot as the most shorted name. Its short interest jumped to 13.19%, up from 11.84% the prior month. Despite the pressure, the heal... Full story

Yahoo Finance • last month

Jan De Witte joins GHO Capital as Operating Partner

Jan De Wittejoins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital’s portfolio London, UK – 11 February 2025: Global Healthcare Opportunities... Full story

Yahoo Finance • last month

ResMed Insiders Sold US$17m Of Shares Suggesting Hesitancy

In the last year, many ResMed Inc. (NYSE:RMD) insiders sold a substantial stake in the company which may have sparked shareholders' attention. Knowing whether insiders are buying is usually more helpful when evaluating insider transactions... Full story

Yahoo Finance • 5 months ago

ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat

ResMed stock broke out early Friday after the CPAP maker broadly beat third-quarter projections, shrugging off weight-loss drug worries. Continue reading View comments... Full story

Yahoo Finance • 5 months ago

ResMed to Report First Quarter Fiscal 2025 Earnings on October 24, 2024

ResMed Inc. SAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2025 on Thursday, October 24, 2024, after the... Full story

Yahoo Finance • 6 months ago

Is ResMed Inc.'s (NYSE:RMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

ResMed's (NYSE:RMD) stock is up by a considerable 26% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Particularly, we will be paying attention t... Full story

Yahoo Finance • 6 months ago

ResMed to Host Its 2024 Investor Day on September 30, 2024, at the New York Stock Exchange

ResMed Inc. Learn more about ResMed’s 2030 strategy to accelerate growth Join in person or via virtual webcast SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) will host an investor day on Monday, September 30,... Full story

Yahoo Finance • 6 months ago

ResMed Insiders Sold US$16m Of Shares Suggesting Hesitancy

The fact that multiple ResMed Inc. (NYSE:RMD) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. Knowing whether insiders are buying is usually more helpful when evaluat... Full story

Yahoo Finance • 7 months ago

ResMed Announces Participation in the Morgan Stanley 22nd Annual Global Healthcare Conference

ResMed Inc. SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, Chairman and Chief Executive Officer, and Dr. Carlos Nunez, Chief Medical Officer, will participate in a fireside chat at... Full story

Yahoo Finance • 7 months ago

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02%

Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Financials, Technology and Telecoms sectors led shares higher. At the close in NYSE, the Dow Jones Industrial Average rose 0.02% to hit a new all time hig... Full story

Yahoo Finance • 10 months ago

MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Data Access

MatrixCare The alliance with Health Gorilla will provide MatrixCare customers with more than 220 million patient records to streamline workflows and improve patient outcomes. BLOOMINGTON, Minn., May 16, 2024 (GLOBE NEWSWIRE) -- MatrixCar... Full story

Yahoo Finance • 11 months ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

Sector Update: Health Care Stocks Edge Higher Late Afternoon... Full story

Yahoo Finance • 11 months ago

ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2024

ResMed Inc. Year-over-year revenue grows 7%, operating profit up 25%, non-GAAP operating profit up 23% Operating cash flows of $402 million Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://in... Full story

Yahoo Finance • last year

ResMed CEO: Weight-Loss Drugs Aren’t Cutting Demand for Sleep Apnea Treatment

As excitement built last year over weight-loss drugs from Novo Nordisk and Eli Lilly investors abandoned companies that treat disorders inflamed by obesity. Shares of ResMed sank 40% from July to October, on fears that fewer people would s... Full story

Yahoo Finance • last year

Q2 2024 Resmed Inc Earnings Call

Participants Amy Wakeham; Chief IR Officer; ResMed Inc. Brett A. Sandercock; CFO; ResMed Inc. Michael J. Farrell; CEO & Chairman; ResMed Inc. Anthony Charles Petrone; MD & Senior Medical Devices, Diagnostics and Therapeutics Equity Res... Full story

Yahoo Finance • last year

ResMed says its masks to remain on market despite FDA classification

Jan 16 (Reuters) - ResMed said its respiratory masks containing magnets will remain on the market even though the U.S. Food and Drug Administration classified a recall of the product as most serious as their use could cause major injuries... Full story

Yahoo Finance • last year

ResMed Announces Participation in the 42nd Annual J.P. Morgan Healthcare Conference

ResMed Inc. SAN DIEGO, Dec. 27, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer and chair of the board, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monda... Full story

Yahoo Finance • last year

ResMed Secures Significant Victory in Patent Fight Against New York University

ResMed Inc. SAN DIEGO, Dec. 11, 2023 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) announced that it has secured a significant victory after the United States Patent Trial and Appeals Board (PTAB) invalidated the claims New York Univer... Full story

Yahoo Finance • last year

ResMed Inc's Dividend Analysis

Assessing the Sustainability and Growth of ResMed Inc's Dividend ResMed Inc(NYSE:RMD) recently announced a dividend of $0.48 per share, payable on 2023-12-14, with the ex-dividend date set for 2023-11-08. As investors look forward to this... Full story

Yahoo Finance • last year

2 Monster Stocks to Buy Without Any Hesitation

First, consumer health juggernaut Kenvue (NYSE: KVUE) produces and markets seven No. 1 global brands. Meanwhile, ResMed (NYSE: RMD), a leader in continuous positive airway pressure (CPAP) machines, has delivered enormous total returns of o... Full story